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SUMMARY
Duodenal obstruction may be caused by inoperable malignant disease. Symptoms ofnausea and
vomiting have been traditionally palliated by surgery. The aim ofthe study was to determine the
efficacy ofthe endoscopic placement ofmetal selfexpanding duodenal stents for the palliation of
malignant duodenal obstruction. Four patients with malignant gastric outlet obstruction are
described. One patient had a history of oesophagectomy for oesophageal adenocarcinoma and
presented with further dysphagia. At endoscopy the recurrent oesophageal tumour and an
adenocarcinoma involving the pylorus were both stented. In the other three patients there was a
previous history of colonic carcinoma, cholangiocarcinoma and oesophageal adenocarcinoma
respectively. All four patients were successfully stented with good palliation oftheir symptoms.
Duodenal Wallstents are a useful alternative to surgery in patients with inoperable malignant
duodenal obstruction or those who are unfit for surgery.
INTRODUCTION
Duodenal obstruction may be caused by
inoperable malignant disease. Symptoms of
nausea and vomiting have been traditionally
palliated by surgery although surgical
gastrojejunostomy is associated with significant
morbidity and mortality.' An endoscopic
alternative to surgery, employing the placement
of self-expanding metal stents across strictures,
has previously been described for malignant
gastricoutletobstruction.2-6Howeverthenumber
ofpatients described inthe literature isrelatively
small and it is not routine practice in many
institutions.
We describe the efficacy of the endoscopic
placement of metal self-expanding duodenal
stents for the palliation of malignant
gastroduodenal obstruction in four patients.
METHODS
Weusedself-expandingmetallic stents(Wallstent
Enteral, Boston Scientific, Microvasive, UK)
22mmindiameterand60-100mminlength.These
stents are constructed from a woven stainless
steel superalloy and have a larger diameter than
the commonly used biliary stents. Before
deployment, these stents are constrained by a
transparent plastic membrane (Unistep System)
onto adelivery systemofouterdiameter 1OFrand
overall length of 230cm. This long thin delivery
system allows the insertion and deployment of
stents through the accessory channel (diameter
4.2mm) of an upper gastrointestinal endoscope.
Stents were placed under endoscopic and
fluoroscopic guidance. Afteridentification ofthe
stricture, we passed a standard 0.035-inch Zebra
guidewire (Boston Scientific, Microvasive, UK)
through it using a standard ERCP catheter. We
determined the length of the stricture by the
distancethecathetertravelled overtheguidewire
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under fluoroscopic monitoring. The Wallstent
Enteral was advanced over the guidewire so that
theends oftheundeployedstentwereequidistant
from the ends of the stricture. We assessed the
adequacy ofstent placement at the conclusion of
eachprocedureusingendoscopyandfluoroscopy.
RESULTS
We carried out the placement of metal self-
expanding duodenal stents in four patients with
malignant gastroduodenal obstruction. All four
patients were unsuitable forsurgical treatment in
view of their advanced disease as assessed by
their attending gastroenterologist and surgeon.
A 57-year old man with a previous history of
distaloesophagectomyandproximalgastrectomy
in 1996foradenocarcinomapresentedwithfurther
dysphagia. Atendoscopy a 5cmmalignant lesion
was evident in the distal oesophagus. A 10cm
length 22mm diameter Wallstent was inserted in
good position. In addition an infiltrating biopsy-
Fig 1. Barium meal demonstrating obstruction between
the second and thirdparts ofthe duodenum(thick
arrow; the thin arrow demonstrates the
gastroenterostomy).
proven adenocarcinoma involving the pylorus
was found and two 7cm length 22mm diameter
Wallstents were inserted successfully in tandem
across the stenosis. The first stent was deployed
toodistaltothe stricture andthe second stentwas
deployedmoreproximallyingoodpositionacross
the stricture with the distal portion overlapping
the first stent. At 2-month follow-up he was
eating normally and gaining weight. He died
from progressive disease four months following
stent insertion.
A 65-year old lady with previous right
hemicolectomy for carcinoma of the colon was
admitted with features of duodenal obstruction
due to local recurrence resulting in extrinsic
compressionbetweenthe secondandthirdpartof
the duodenum. An initial attempt at endoscopic
placement of a duodenal stent was unsuccessful
due to equipment incompatibility. A bypass
gastroenterostomyandanteriorgastrostomywere
performed. The former was complicated by
retrograde intussusception of the efferent loop
andresultedinfurthervomitingandalargegastric
aspirate (Figure 1). Repeatendoscopy confirmed
extrinsic compression between the second and
third part of the duodenum and a 6cm length
22mm Wallstent was successfully placed across
the extrinsic compression with resolution of her
vomiting and a marked reduction in the amount
of gastric aspirate (Figure 2). The anterior
gastrostomy was then allowedto close over once
theduodenal stenthadbeeninsertedsuccessfully
endoscopically. She wasdischargedhome aftera
six-week admission and had a two-month period
ofgoodsymptomcontrolbeforebeingre-admitted
with symptoms due to an obstructed stent caused
by tumour ingrowth. An unsuccessful attempt
was made to insert a further stent in tandem in
order to relieve the obstruction and co-existent
distal smallbowelobstruction oncontraststudies
was also noted at that time. A defunctioning
percutaneous gastrostomy was performed for
symptom palliation. She died a short time later.
A 64-year old man had a history of inoperable
cholangiocarcinoma and was palliated two years
previously by means of a hepaticojejunostomy.
HepresentedwithrecurrentvomitingandBarium
meal demonstrated a stricture due to extrinsic
compression as aresultofrecurrenttumourinthe
second part of the duodenum with no flow of
contrast beyond. A 9cm 22mm Wallstent was
inserted across the stricture and provided good
symptomaticrelief.Followingendoscopyroutine
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Fig 2. Endoscopic deploymentoftheduodenal stentbetweenthe secondandthirdparts oftheduodenum (arrowpointing
to duodenal stent).
Gastromiro meal was suspicious of a small
contained perforation in the proximal part ofthe
secondpartoftheduodenum. Hehadnosymptoms
and was treated conservatively with intravenous
antibiotics, parenteral nutrition and was fit for
dischargeafter 1 week. Hesubsequentlytolerated
a light diet and remained well for four months at
which time he developed ascites and died one
month later.
A 56 year old man with adenocarcinoma arising
from the gastro-oesophageal junction had
undergone oesophagectomy 14 months earlier.
He presented with vomiting, abdominal pain,
weightlossandcachexia. CTscanofhisabdomen
showed soft tissue around the aorta in the
diaphragmatic crus and softtissue adjacent tothe
duodenal loop. There was abdominal ascites.
Barium meal showed delayed gastric emptying
from a narrow pyloric channel. While in hospital
he was noted to have significant vomiting and
was unable to keep any fluids down. At upper
gastrointestinal endoscopy, there was a large
amountofgastric residue due to pyloric stenosis,
probably from tumour infiltration, and the
duodenum could not be entered. A therapeutic
duodenoscope (Olympus) was used. A Zebra
guidewire(BostonScientific) wasinsertedacross
thepyloric stenosisunderfluoroscopic guidance.
A 9cm long, 2.2cm diameter uncovered enteral
Wallstent(BostonScientific)waspassedthrough
the scope and deployed across the pylorus. A
routine post procedure Gastromiro swallow
showed that most ofthe contrast passed through
the stent. Following the procedure he was able to
tolerate a soft diet. He was discharged 2 days
after the procedure.
DISCUSSION
The management of malignant gastroduodenal
obstruction is difficult. Our patients were
unsuitable for surgery in view of their advanced
disease.Whilstsupportivecareiscommonlyused,
it neitherrelieves nausea orvomiting, nor allows
anadequatefoodintake. Surgicaloptions include
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gastrojejunostomyorantralgastrectomy,although
these are associated with significant morbidity
andmortality.' Othertreatmentoptions, including
chemotherapy and radiotherapy, are not helpful
in relieving symptoms. The combination of a
surgically placed jejunostomy for feeding
purposes and a defunctioning percutaneous
endoscopic gastrostomy has been used, but is
oftenunsatisfactory.7 Endoscopic dilatation only
provides transientreliefofsymptoms and carries
a significant risk ofperforation.
We have found that the placement of self-
expanding metallic Wallstents is a safe and
effective alternative to surgery in patients with
inoperable malignant duodenal obstruction. The
slim and flexible delivery system allows stent
placement into the angulated parts of the upper
gastrointestinaltractwithoutpriordilatation. The
larger diameter ofthese stents allows patients to
resume a normal diet. This advantage has also
been confirmed in one of the largest studies to
date.8 Twelve patients with malignant
gastroduodenal obstruction were followed up, of
whom 6 were able to resume aregular diet, three
could eat pureed food, in two patients the
procedure was unsuccessful due to technical
reasons and one patient had coexistent distal
small intestinal obstruction.8 One ofour patients
may have had a small contained perforation. An
estimate ofthe incidenceofperforationrelatedto
theplacementofduodenal stents is limitedbythe
small size of the studies. In one study of 31
patients, oneperforationoccurred,representing a
complication rate of 3%.9 An alternative to
endoscopic placement is stent placement under
fluoroscopic control.'0
The use ofWallstents for the relief ofmalignant
gastric outlet obstruction is more cost-effective
than surgical gastrojejunostomy."1 In addition,
stenting can be expected to provide a greater
quality of life and there is less time required for
convalescence. In one study, the median survival
time for patients who underwent enteral stent
placement compared with those who underwent
surgical gastrojejunostomy was 94 and 92 days,
charges were $9,921 and $28,173 (p=<0.005)
andduration ofhospitalization was 4 and 14 days
(p=<0.005), respectively."
In conclusion, recent studies suggest that the
endoscopic placement of enteral stents provides
a feasible and effective means ofthe palliation of
obstructive symptoms due to malignant
gastroduodenalobstructionandmaybepreferable
tosurgeryalthoughconfirmationofthisisawaited
from randomised controlled trials.
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